Addressing industry challenges in mRNA product commercialization

Webinar On Demand

The rapid development and approval of mRNA-based vaccines during the COVID-19 pandemic has spurred a renewed interest in mRNA technology, with scientists exploring new application areas such as oncology, HIV, rare diseases, and even personalized medicine.

While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use. Watch this on-demand webinar regarding key challenge areas for mRNA-based product developers and the innovative strategies being used to address them.